NCT00306033View on ClinicalTrials.gov

Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

May 31, 2005

Conditions
Myasthenia Gravis
Interventions
DRUG

Intravenous ImmuneGlobulin

Trial Locations (1)

M5G 2N2

University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT00306033 - Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis | Biotech Hunter | Biotech Hunter